‘Shareholder value’ versus the public good: the case of Germany

“With uncertainty around the world about how and when the coronavirus outbreak will decelerate, whole business sectors have been affected by lockdowns and are facing ruin. In Germany, more than 750,000 companies have put over 12 million employees on reduced working…

Featured

Think Big Pharma Won’t Profiteer in the Race to Treat Coronavirus? Think Again.

“In a 2019 Gallup poll, Big Pharma ranked as the most disliked industry in America. Rosie Collington, a graduate student at the University of Copenhagen and a researcher at the Academic-Industry Research Network, knows why: She has studied how major insulin manufacturing…

Featured

With working Americans’ survival at stake, the US is bailing out the richest

“Amid a humanitarian crisis compounded by mass layoffs and collapsing economic activity, the last course our legislators should be following is the one they appear to be on right now: bailing out shareholders and executives who, while enriching themselves, spent…

Featured

Top Economist: Instead of Basic Income, Let’s Keep People Working Productively During the Crisis

“As the pandemic rages, everyone is scrambling to figure out how to protect people getting economically pummeled. Americans may soon get a cash injection to help them fight the economic devastation of Covid-19 as part of a stimulus bill agreed…

Featured

4 Ways to Eradicate the Corporate Disease That is Worsening the Covid-19 Pandemic

“It’s time for business executives, employees, and taxpayers to come together to help get us out of the pandemic and create conditions for a sustainable and equitable future Here are the key ways to respond to the coronavirus crisis and…